Navigation Links
Lexicon Completes Phase 2 Study Of LX1033 In IBS-d
Date:12/3/2013

tment arms and placebo.

"While LX1033 showed similar improvements in stool consistency as compared to the placebo patients who completed the study, there were positive effects on abdominal pain in the treated group that warrant further study," said Pablo Lapuerta, M.D., Lexicon's chief medical officer. "While this initial Phase 2a study was underway, we completed long-term toxicology studies which would allow us to conduct a Phase 2b study at doses informed by the current results and with a duration of 12 weeks, a treatment period that has historically been important to identify clinically meaningful changes as compared to placebo."

In this Phase 2 study of IBS-d, 373 patients were randomized to be treated for 28 days with either placebo or one of three different dose levels of LX1033 for 28 days, 1000 mg twice daily, 500 mg twice daily, and 500 mg three times daily. The primary endpoint was the change from baseline in stool consistency as evaluated by the Bristol Stool Form Scale. A key secondary endpoint was the change from baseline in abdominal pain, and other endpoints included the change in plasma 5-HIAA.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-lookin
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014  Marta Rendon, MD, founder of ... Boca Raton , FL and international key opinion leader in ... the United States to attend the ... Istanbul, Turkey . Here, at this gathering of over ... world renowned facial plastic surgery experts from Asia ...
(Date:11/24/2014)... -- GlySens Incorporated announced today that it has been awarded ... Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), ... The grant is intended to support human clinical evaluation ... glucose monitoring system.  Final preparations for launch of the ... before the end of 2014. "We are ...
(Date:11/23/2014)... -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... and Chief Executive Officer, will present a corporate update ... Anthera will present at 4:30PM ET, December ... New York City . ... biopharmaceutical company focused on developing and commercializing products to ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2
... Next Generation Pharmaceutical Manufacturing Europe will take ... and will provide leading executives with an ideal framework ... summit has elected more than 50 of the most ... will include Bo Hilligsøe, VP Finished Goods Production, H.Lundbeck; ...
... Omnicell, Inc . (NASDAQ: OMCL ... solutions and analytics software for healthcare facilities, today announced ... medication automation products for clinical use in China. ... Chinese hospitals to access advances in operational improvements similar ...
Cached Medicine Technology:The Next Generation Pharmaceutical Manufacturing Summit 2Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 2Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 3Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 4Omnicell Introduces Groundbreaking Mandarin-Language Medication Automation System for Use in Chinese Clinical Settings 5
(Date:11/23/2014)... TX (PRWEB) November 23, 2014 ... market such as its significance, programs and manufacturing ... and Chinese suppliers major market gamers in information. ... information, item specifications, prospective, manufacturing value, and 2009-2014 ... research, the evaluation symbolizes the globally and Chinese ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online ... wedding dresses. “If you are looking for gorgeous beach ... as possible. Here you can enjoy 70% off discounts ... Holding a big marriage ceremony is the most important ... wedding dress is uppermost priority. Ophelia, one of customers, ...
(Date:11/23/2014)... 2014 “BlackVue” was featured on NewsWatch ... which features the latest and coolest technology products available ... for NewsWatch, conducted the product review and shared with ... options in the car camera industry. , The need ... be hard to find the one that’s right per ...
(Date:11/23/2014)... Syngenta lawsuits are now being investigated by ... agribusinesses that have allegedly incurred significant financial damages due ... Agrisure Duracade, genetically modified (GMO) corn seed products ... China. According to a report from Bloomberg News, Syngenta’s ... imports. Because China is the third-largest American corn importer, ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3
... an important signaling pathway that, when blocked, significantly decreases ... their study, researchers at The University of Texas MD ... the Notch pathway in mice decreased metastases in the ... studies were reported Sunday in an oral presentation at ...
... MADISON Researchers may have pinpointed a reason many ... in the journal Addiction, smokers with a history of ... study, conducted by the University of Wisconsin Center for ... medications to smokers in Madison and Milwaukee. , While ...
... The arteries of obese children have a degree of stiffness ... new study. Canadian researchers evaluated 63 obese children, average ... had abnormal results on an ultrasound test of the heart ... the body. Of special note was stiffness of ...
... new tools that enable the public to report sick or ... containment of wildlife disease outbreaks that may pose a health ... is a new website at www.wher.org that enables ... or dead wildlife. ,HealthMap.org has enhanced its mobile phone ...
... Behen HealthDay Reporter , SUNDAY, Oct. 24 (HealthDay ... topic of late: Just last week, the National Football League ... hits that often result in head injuries. Now, a ... years, players have been sidelined significantly longer after concussions than ...
... of a number of new Canadian Cardiovascular Society ... to date information to support clinicians in practicing ... Congress 2010 this week. Among them are the ... antiplatelet therapy guidelines , CCS position statement on ...
Cached Medicine News:Health News:Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies 2Health News:Common anxiety disorders make it tougher to quit cigarettes 2Health News:Arteries of Obese Kids Aging Prematurely: Study 2Health News:Wildlife health reporting tools may help prevent human illness 2Health News:Wildlife health reporting tools may help prevent human illness 3Health News:NFL Players With Concussions Sidelined Longer: Study 2Health News:NFL Players With Concussions Sidelined Longer: Study 3Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 2Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 3Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 4Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 5Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 6Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 7Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 8Health News:Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010 9
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
Medicine Products: